1.	Timed-Sequential Induction in CBF-AML Phase: Phase III Type: Treatment Status: Active Age: 18 to 60 Sponsor: Other Protocol IDs: P060504, NCT00428558
2.	A Non-inferiority Study Comparing Two Filgrastim Preparations in Breast Cancer Phase: Phase III Type: Supportive care Status: Active Age: 18 and over Sponsor: Other Protocol IDs: EF-026, NCT01079676
3.	Gemcitabine, Paclitaxel, Ifosfamide, and Cisplatin in Treating Patients With Progressive or Relapsed Metastatic Germ Cell Tumors Phase: Phase II, Phase I Type: Treatment Status: Active Age: 16 to 60 Sponsor: Other Protocol IDs: CDR0000572096, USCTU-UR1002-GEM-TIP, EU-20769, EUDRACT-2004-004804-19, UR1002-Gem-TIP, NCT00551122
4.	Fludarabine and Cytarabine as Continuous Infusion Plus G-CSF Priming for Elderly Patients With Resistant AML Phase: Phase II Type: Treatment Status: Active Age: 60 to 80 Sponsor: Other Protocol IDs: C-008, NCT00529880